Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome.

Abstract excerpt

We report a retrospective analysis of bromide therapy in 32 patients suffering from Dravet syndrome with SCN1A-mutations who received bromide. After 3 months of bromide treatment, 26 patients (81%) showed a relevant improvement with a reduction of seizure frequency by >50% (>75%) in 18 (12) patients (56 and 37%, respectively). After 12 months, we observed a reduction of >50% (>75%) in 15 (9) patients (47 and 28%,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticonvulsants
• Share to Child, Preschool
• Share to Epilepsies, Myoclonic